Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

63.37 +0.06 (+0.09%)
Streaming Delayed Price Updated: 2:55 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 469,206
Open 63.17
Bid (Size) 63.34 (3)
Ask (Size) 63.40 (5)
Prev. Close 63.31
Today's Range 62.84 - 64.30
52wk Range 53.56 - 83.95
Shares Outstanding 222,430,635
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States
From Incyte
Via Business Wire
INCY Q1 Earnings Call: New Product Launches and Pipeline Progress Drive Outperformance
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 19.5% year on year to $1.05 billion. Its non-GAAP profit... 
Via StockStory
Topics World Trade
Exposures Tariff

Performance

YTD
-8.9%
-8.9%
1 Month
+11.6%
+11.6%
3 Month
-11.1%
-11.1%
6 Month
-17.7%
-17.7%
1 Year
+10.8%
+10.8%

More News

Read More
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Via Chartmill
Earnings Scheduled For April 29, 2025
Via Benzinga
INCYTE CORP (NASDAQ:INCY), an undervalued stock with good fundamentals.
Via Chartmill
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Incyte
Via Business Wire
Incyte to Present at Upcoming Investor Conference
From Incyte
Via Business Wire
INCYTE CORP (NASDAQ:INCY) – A Look at Its Dividend Potential
Via Chartmill
9 Analysts Have This To Say About Incyte
Via Benzinga
Discover the top S&P500 movers in Tuesday's after-hours session.
Via Chartmill
Tuesday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
3 Value Stocks Facing Headwinds
Via StockStory
Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday?
Via Benzinga
Topics Bonds
Exposures Debt Markets
Incyte (NASDAQ:INCY) Delivers Strong Q1 Numbers
Via StockStory
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
From Incyte
Via Business Wire
Incyte (INCY) Q1 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence Government World Trade
Exposures Artificial Intelligence Political Tariff
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025
From Incyte
Via Business Wire
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Incyte
Via Business Wire
INCYTE CORP (NASDAQ:INCY) is probably undervalued for the fundamentals it is displaying.
Via Chartmill
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Incyte to Report First Quarter Financial Results
From Incyte
Via Business Wire
What's going on in today's session: S&P500 movers
Via Chartmill
These S&P500 stocks are gapping in today's session
Via Chartmill
Tech Stocks Rebound As US Treasuries Tumble: What's Driving Markets Wednesday?
Via Benzinga
Topics World Trade
Exposures Tariff

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 63.37
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 05/19/25 02:55 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 14.10B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.